AAFCPAs would like to make healthcare clients aware of a potential cost savings on an Inter-Uterine Device (IUD) for eligible patients. Medicines360 has received FDA approval for an IUD, named LILETTA®. Medicines360 is a nonprofit pharmaceutical company, and as part of their mission, they are making LILETTA® available at a reduced, fixed price of $50.00 to clinics enrolled in the 340B Drug Pricing program. Medicines360 has reported that this price will never increase. Many 340B covered entities are currently paying $500 – $2,000 per device, so LILETTA may offer a significant cost savings.
340B covered entities may visit the LILETTA website for more information on procurement, billing and benefits. AAFCPAs encourage clients to analyze which patients might qualify, and assess the benefit and cost savings this product may provide to the 340B covered entity and its patients. We also encourage you to fully understand reimbursement rates and how billing procedures for the LILETTA would affect your current processes.
More information is available at www.LILETTAAccessConnect.com or by calling 855.545.3882.
AAFCPAs delivers a full range of solutions solving the challenges that AAF’s healthcare clients face, including: guidance on compliance with 340B pharmacy program requirements, and program audits of both on-site and contract pharmacies. If you have any questions or need additional information, please contact your AAF Partner, or Courtney McFarland, CPA: 774.512.4051, firstname.lastname@example.org.